Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: ETF
  • Objective: Health Care
  • Asset Class: Equity
  • Geographic Focus: U.S.

Market Vectors Pharmaceutical ETF

+ Add to Watchlist

VEFV:GR

64.9000 EUR 0.0400 0.06%

As of 14:21:03 ET on 03/27/2015.

Snapshot for Market Vectors Pharmaceutical ETF (VEFV)

Open: 64.5100 High - Low: 65.1700 - 64.5100 Primary Exchange: Berlin
Volume: 0 52-Week Range: 39.6100 - 67.3000 Beta vs MVPPHTR: 0.9448

ETF Chart for VEFV

No chart data available.
  • VEFV:GR 64.9000
  • 1D
  • 1M
  • 1Y
64.8600
Interactive VEFV Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for VEFV

Market Vectors Pharmaceutical ETF is an exchange-traded fund incorporated in the USA. The Fund seeks to track the performance of the US Listed Pharmaceutical 25 Index.

Inception Date: 2009-03-20 Telephone: 1-212-293-2000
Managers: PETER LIAO / GEORGE CAO
Web Site: www.vaneck.com

Fundamentals for VEFV

NAV -
Assets (M) (on 2015-03-26) 371.5191
Shares out (M) 0.00
Market Cap (M) 0.00
% Premium -
Average 52-Week % Premium -
Fund Leveraged N

Dividends for VEFV

Dividend Type Income
Dividend Frequency Quarter
Last Dividend Net (on 2014-12-29) 0.2439
Dividend Yield (ttm) 1.28%

Performance for VEFV

1-Month +4.58% 1-Year +57.99%
3-Month +20.73% 3-Year +35.79%
Year To Date +21.51% 5-Year -
Expense Ratio 0.35

Top Fund Holdings for VEFV

Filing Date: 03/26/2015
Name Position Value % of Total
Novartis AG 351,268 34,972,242 9.420%
Johnson & Johnson 315,331 31,577,246 8.506%
Pfizer Inc 736,917 25,173,085 6.781%
Novo Nordisk A/S 389,384 20,738,592 5.586%
Sanofi 381,751 18,629,449 5.018%
Actavis plc 61,175 18,433,251 4.965%
Merck & Co Inc 319,579 18,407,750 4.958%
GlaxoSmithKline PLC 392,627 18,319,976 4.935%
AstraZeneca PLC 250,218 17,457,710 4.703%
Eli Lilly & Co 235,525 17,296,956 4.659%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil